BeNeLuxA(Ir) is a joint negotiation procedure for timely and affordable access to very specific innovative drugs in Belgium, The Netherlands, Luxembourg, Austria and Ireland. This can be applied with complex and rare (innovative) medicines, with a higher cost per patient and a relatively high budget impact.
The BeNeLuxA(Ir) initiative is growing and gaining importance; in addition similar networks have been established in Europe to perform joint negotiations for medicines.
Innosens has a large network in- and outside of Belgium with the relevant stakeholders to provide you with the necessary support for this procedure.
Innosens can support its clients with its vast and substantial network and the years of experience in the negotiation procedures.
If you would like to know more about the BeNeLuxA(Ir) procedure, feel free to contact us.